Well-designed clinical nutrition trials should measure baseline biomarkers, genetic polymorphisms, blood levels during intervention, other regulatory proteins, and clinical outcomes; a large upcoming vitamin D trial will enroll thousands of participants with diverse ages and genders, supplement with 2,000 IUs daily, and comprehensively measure vitamin D biomarkers and genetic variants alongside clinical outcomes—this represents the future standard for nutrition research
normativepending
Speaker
Rhonda PatrickEvidence Quote
“They're going to measure blood levels of vitamin D... other proteins that regulate vitamin D... gene polymorphisms... clinical outcomes. And I think that's the way we should be doing clinical trials”
Source
Rhonda Patrick on Diet-Gene Interactions, Epigenetics, the Vitamin D-Serotonin Link and DNA Damage— TheIHMCCreated: 8/11/2026, 1:34:17 AM
Your notes
Loading notes...